T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.06% |
| 2 | Financials | 16.98% |
| 3 | Consumer Discretionary | 15.13% |
| 4 | Technology | 13.74% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Churchill Downs
CHDN
$6.33B
| $26.9M | 0.01% |
1,070,862
+19,950
| +2% | +$487K |
|
1027
Quest Diagnostics
DGX
$25.9B
| $26.8M | 0.01% |
291,840
-2,240
| -0.8% | -$193K |
|
1028
World Kinect Corp
WKC
$1.85B
| $26.7M | 0.01% |
581,858
+18,438
| +3% | +$822K |
|
1029
Huntington Bancshares
HBAN
$36.2B
| $26.7M | 0.01% |
2,020,565
-11,914
| -0.6% | -$139K |
|
|
SPLS
1030
DELISTED
Staples Inc
SPLS
| $26.5M | 0.01% |
2,930,638
-1,611,600
| -35% | -$14M |
|
1031
Editas Medicine
EDIT
$433M
| $26.5M | 0.01% |
1,631,534
-242,862
| -13% | -$3.69M |
|
|
CTRA
1032
DELISTED
Coterra Energy
CTRA
| $26.5M | 0.01% |
1,133,490
-5,000
| -0.4% | -$112K |
|
|
AAT
1033
American Assets Trust
AAT
$1.4B
| $26.3M | 0.01% |
611,470
-490
| -0.1% | -$20K |
|
1034
iShares Russell 2000 ETF
IWM
$82.9B
| $26.3M | 0.01% |
194,684
| – | – |
|
1035
Patrick Industries
PATK
$2.76B
| $26.2M | 0.01% |
773,685
+119,891
| +18% | +$3.54M |
|
1036
Genesco
GCO
$391M
| $26.2M | 0.01% |
422,280
-42,420
| -9% | -$2.59M |
|
|
P
1037
DELISTED
Pandora Media Inc
P
| $26.2M | 0.01% |
2,010,655
-124,693
| -6% | -$1.55M |
|
1038
AdvanSix
ASIX
$460M
| $26.2M | 0.01% |
+1,182,929
| New | +$21.3M |
|
|
SIX
1039
DELISTED
Six Flags Entertainment Corp.
SIX
| $26.2M | 0.01% |
436,647
+5,163
| +1% | +$289K |
|
|
MRO
1040
DELISTED
Marathon Oil Corporation
MRO
| $26.2M | 0.01% |
1,511,417
+13,040
| +0.9% | +$209K |
|
|
CFCOU
1041
DELISTED
CF Corporation
CFCOU
| $26.1M | 0.01% |
2,496,597
-4,703
| -0.2% | -$48.6K |
|
1042
Jack Henry & Associates
JKHY
$10.9B
| $26.1M | 0.01% |
293,932
+9,963
| +4% | +$850K |
|
1043
WisdomTree
WT
$3.46B
| $26.1M | 0.01% |
2,342,270
+298,220
| +15% | +$3.11M |
|
1044
Healthpeak Properties
DOC
$14.3B
| $26.1M | 0.01% |
877,770
-83,298
| -9% | -$2.54M |
|
1045
NOV
NOV
$7.54B
| $26M | 0.01% |
695,756
-311
| -0% | -$11.3K |
|
1046
Genuine Parts
GPC
$18.6B
| $26M | 0.01% |
272,084
+90
| +0% | +$8.58K |
|
1047
Arthur J. Gallagher & Co
AJG
$64.4B
| $25.9M | 0.01% |
497,640
+52,100
| +12% | +$2.62M |
|
1048
F5
FFIV
$22.8B
| $25.8M | 0.01% |
178,255
-1,250
| -0.7% | -$169K |
|
|
WFBI
1049
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $25.8M | 0.01% |
889,850
+388,546
| +78% | +$9.79M |
|
|
CBM
1050
DELISTED
Cambrex Corporation
CBM
| $25.7M | 0.01% |
477,230
+470
| +0.1% | +$22.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.